Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleocapsid Protein scFv Antibody from ABBEXA LTD
Search, find, compare suppliers for anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleocapsid Protein scFv antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleocapsid Protein scFv |
| Clone | monoclonal |
| Host Species | Recombinant |
| Reactive Species | n/a |
| Isotype | IgG1 |
| Format | unconjugated |
| Size | 100 µl, 1 ml, |
| Concentration | 1 mg/ml |
| Applications | ELISA |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein scFv antibody is a recombinant monoclonal antibody expressed in E. coli against SARS-CoV-2/COVID-19 NP scFv. The SARS-CoV-2 Nucleoprotein (also known as Nucleocapsid Protein or N Protein) is a protein that binds to the RNA in the viral particle. Changes to two amino acids in the nucleoprotein are thought to contribute to the virus' ability to infect humans; this mutation allows the virus to reduce the binding capability of an HLA-C allele found in many Europeans. The nucleoprotein is the second most-common protein in SARS-CoV-2 targeted by the immune system, after the spike protein. |
| Immunogen | n/a |
| Other Names | Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV-2, COVID-19, 2019-nCoV, 2019 novel coronavirus, COVID19, SARS-CoV-2 NP, SARS-CoV-2 Nucleocapsid, SARS-CoV-2 Nucleoprotein, Severe Acute Respiratory Syndrome Coronavirus 2, Severe Acute Respiratory Syndrome Coronavirus 2 , Severe Acute Respiratory Syndrome Coronavirus 2 , Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV-2, SARS-CoV-2 , SARS-CoV-2 , SARS-CoV-2, COVID-19, COVID-19 , COVID-19 , COVID-19, 2019-nCoV, 2019-nCoV , 2019-nCoV , 2019-nCoV, 2019 novel coronavirus, 2019 novel coronavirus , 2019 novel coronavirus , 2019 novel coronavirus, COVID19, COVID19 , COVID19 , COVID19, SARS-CoV-2 NP, SARS-CoV-2 NP , SARS-CoV-2 NP , SARS-CoV-2 NP, SARS-CoV-2 Nucleocapsid, SARS-CoV-2 Nucleocapsid , SARS-CoV-2 Nucleocapsid , SARS-CoV-2 Nucleocapsid, SARS-CoV-2 Nucleoprotein, SARS-CoV-2 Nucleoprotein , SARS-CoV-2 Nucleoprotein , SARS-CoV-2 Nucleoprotein |
| Gene, Accession # | Gene ID: 43740575, UniProt: P0DTC9 |
| Catalog # | abx226549 |
| Price | please inquire |
| Order / More Info | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleocapsid Protein scFv Antibody from ABBEXA LTD |
| Product Specific References | n/a |
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950
Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com
https://www.abbexa.com
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950
Profile of ABBEXA LTD
Return to Antibodies